BSB
MRNA icon

Bangor Savings Bank’s Moderna MRNA Stock Holding History

Bangor Savings Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-360
Closed -$43.7K – 547
2023
Q2 		$43.7K Hold
360
– – 0.01% 310
2023
Q1 		$55.3K Hold
360
– – 0.01% 288
2022
Q4 		$65K Hold
360
– – 0.01% 274
2022
Q3 		$43K Buy
+360
New +$54.6K 0.01% 310

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Bangor Savings Bank's MRNA Position: Q3 2023 in Review

Bangor Savings Bank sold out of Moderna (MRNA) in Q3 2023, closing a stake of 360 shares — an estimated $43.7K sold.

Bangor Savings Bank first reported a position in MRNA in Q3 2022 and held it in 4 quarters. The position peaked at $65K in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Bangor Savings Bank reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Bangor Savings Bank sold 360 Moderna shares in Q3 2023, an estimated $43.7K.
  • Bangor Savings Bank first reported a position in Moderna in Q3 2022 and held it in 4 quarters.
  • Bangor Savings Bank's Moderna position peaked at $65K in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Bangor Savings Bank's 13F filing for Q3 2023, filed 24 Oct 2023.